Enuresis, commonly referred to as bedwetting, is the involuntary release of urine during sleep in children over 5 years of age. ‘Enuresis’ is reserved for nighttime wetting, while daytime wetting is classified separately as urinary incontinence. Enuresis can be further categorised as primary, where the child has never achieved a prolonged dry period, and secondary, where bedwetting recurs after at least 6 months of dryness.
The condition affects up to 10% of 5-year-olds and tends to decrease with age, with only about 1% of those aged 15 and older still affected. Boys are twice as likely to experience enuresis compared to girls. Emotional support and a non-punitive approach from parents/carers are essential, as bedwetting can affect self-esteem and psychological wellbeing.
Enuresis involves a discrepancy between nocturnal urine production and functional bladder capacity, coupled with an inability to wake from sleep when the bladder is full. Additional aetiological factors include nocturnal polyuria (such as from lack of nocturnal antidiuretic hormone secretion), abnormally reduced bladder capacity, and sleep arousal disorders.
Risk factors for enuresis include:
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas eu odio in nibh placerat tempor ac vel mauris. Nunc efficitur sapien at nisl semper dapibus. Nullam tempor eros sed dui aliquam lacinia. Nunc feugiat facilisis ex.
Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae; Maecenas mauris nibh, tempus sit amet erat vel, pellentesque maximus ipsum. Suspendisse dui nunc, porta ac ultricies id, sodales eu ante.
The Medcast medical education team is a group of highly experienced, practicing GPs, health professionals and medical writers.
Become a member and get unlimited access to 100s of hours of premium education.
Learn moreFrom 1 Nov 2025, the Australian government is making important changes with the Bulk Billing Practice Incentive Program (BBPIP). This FastTrack is a concise summary of how to make the most of the BBPIP, from registration, eligibility considerations, and a step-by-step approach to preparing your practice for the changes.
Two of the four core palliative care medicines are clonazepam and haloperidol, used respectively to manage anxiety and emesis in end-of-life patients. This FastTrack highlights the role of the GP in treating these two common symptoms, focusing on pharmacological strategies. 30mins each of RP and EA CPD available with the quiz.
Iron deficiency is the most common nutritional disorder around the world, affecting a disproportionate number of women. This FastTrack provides a concise summary of iron replacement in pre-menopausal women, with specific attention to menstruation and pregnancy-related iron deficiency. 30mins each of RP and EA CPD available with the quiz.